Michael Peregrine and Stephen Wu wrote this bylined article which noted that, although healthcare executives and board members are sensitive to the antitrust issues arising from merger transactions, “they have far less awareness of conduct that could lead to criminal allegations; e.g., price-fixing and market allocation” from government regulators. The authors thus emphasized “the value of focused internal education on antitrust compliance beyond the M&A context.” Read the full article.
